{"id":1092,"date":"2025-09-17T19:56:26","date_gmt":"2025-09-17T19:56:26","guid":{"rendered":"https:\/\/www.bilgitarif.com\/iyi\/?p=1092"},"modified":"2025-09-17T19:56:38","modified_gmt":"2025-09-17T19:56:38","slug":"bu-ilaci-sakin-kullanmayin","status":"publish","type":"post","link":"https:\/\/www.bilgitarif.com\/iyi\/bu-ilaci-sakin-kullanmayin\/","title":{"rendered":"Bu \u0130lac\u0131 Sak\u0131n Kullanmay\u0131n"},"content":{"rendered":"

\"\"<\/a> Sak\u0131n Bu \u0130lac\u0131 Kullanmay\u0131n
\nD\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc Uyard\u0131 Sak\u0131n Kullanmay\u0131n.. devam\u0131 snraki syfada..
\n
\nD\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc Uyard\u0131 Sak\u0131n Kullanmay\u0131n<\/p>\n

T\u00fcrkiye ve D\u00fcnya \u015fokta bu ilac\u0131 sak\u0131n kullanmay\u0131n evinizde varsa an\u0131nda at\u0131n.. Ayr\u0131nt\u0131lar Haberin Detay\u0131ndad\u0131r\u2026 Evinizde varsa kullanmay\u0131n S\u0131hhat Bakanl\u0131\u011f\u0131 uyard\u0131: O ilac\u0131 sak\u0131n kullanmay\u0131n. S\u0131hhat Bakanl\u0131\u011f\u0131, Ds\u00f6 a\u00e7\u0131klad\u0131 T\u00fcrkiyede oldu\u011funu s\u00f6yledi ve kullan\u0131m\u0131 \u00f6l\u00fcmle sonu\u00e7lan\u0131r dedi detaylar haberimizin devam\u0131ndad\u0131r. Sak\u0131n kullanmay\u0131n kontrol edin.D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6) Hindistan ve T\u00fcrkiye\u2019de sat\u0131lan sahte ila\u00e7lara ili\u015fkin a\u00e7\u0131klama yapt\u0131. Karaci\u011fer hastal\u0131klar\u0131nda kullan\u0131lan DEFITELIO adl\u0131 sahte ilaca ka\u015f\u0131 uyar\u0131da bulunan DS\u00d6, ilac\u0131n \u00f6l\u00fcme varan sa\u011fl\u0131k risklerinin oldu\u011funu belirtti. DS\u00d6 taraf\u0131ndan yap\u0131lan a\u00e7\u0131klamada, \u201cBu DS\u00d6 T\u0131bbi \u00dcr\u00fcn Uyar\u0131s\u0131, DEFITELIO\u2019nun (defibrotide sodium) bir sahte partisine at\u0131fta bulunmaktad\u0131r. Bu sahte \u00fcr\u00fcn Hindistan (Nisan 2023) ve T\u00fcrkiye\u2019de (Temmuz 2023) tespit edilmi\u015f olup, yetkili kanallar d\u0131\u015f\u0131nda tedarik edilmi\u015ftir.\u201d denildi.KARAC\u0130\u011eER HASTALIKLARININ TEDAV\u0130S\u0130NDE KULLANILIYOR<\/p>\n

DS\u00d6\u2019n\u00fcn bildirdi\u011fine g\u00f6re DEFITELIO, hematopoetik k\u00f6k h\u00fccre transplantasyonu (HSCT) tedavisinde sin\u00fczoidal obstr\u00fcktif sendrom (SOS) olarak da bilinen \u015fiddetli hepatik veno-okl\u00fczif hastal\u0131\u011f\u0131n (VOD) tedavisinde kullan\u0131l\u0131yor. VOD, karaci\u011ferdeki damarlar\u0131n t\u0131kand\u0131\u011f\u0131 ve organ\u0131n do\u011fru \u00e7al\u0131\u015fmas\u0131n\u0131 engelledi\u011fi bir duruma deniliyor.<\/p>\n

H\u0130ND\u0130STAN VE T\u00dcRK\u0130YE UYARISI<\/p>\n

Bununla birilikte DS\u00d6, DEFITELIO\u2019nun orijinal \u00fcreticisinin, s\u00f6z konusu uyar\u0131da at\u0131fta bulunulan \u00fcr\u00fcn\u00fcn sahte oldu\u011funu da belirtti. DS\u00d6 \u015fu ifadeleri kulland\u0131: \u201cOrijinal \u00fcretici \u015funu bildirmi\u015ftir: 20G20A Lotlu orijinal DEFITELIO Almanya\/Avusturya ambalaj\u0131nda paketlenmi\u015f olup, sahte \u00fcr\u00fcnler bunun yerine \u0130ngiltere\/\u0130rlanda ambalaj\u0131ndad\u0131r.Belirtilen son kullanma tarihi tahrif edilmi\u015ftir ve kay\u0131tl\u0131 raf \u00f6mr\u00fcne uymamaktad\u0131r. Belirtilen seri numaras\u0131 20G20A partisi ile ili\u015fkili de\u011fildir. \u0130lac\u0131n Hindistan ve T\u00fcrkiye\u2019de ruhsat\u0131 bulunmamaktad\u0131r.\u201d Bu, DS\u00d6\u2019n\u00fcn s\u00f6z konusu ilaca kar\u015f\u0131 yay\u0131nlad\u0131\u011f\u0131 ilk uyar\u0131 de\u011fil. DS\u00d6, 7 May\u0131s 2020\u2019de sahte ilac\u0131n Arjantin, Avustralya, Letonya, Malezya ve Suudi Arabistan gibi \u00fclkelerde sat\u0131ld\u0131\u011f\u0131n\u0131 tespit etmi\u015fti.\u00d6L\u00dcME VARAN SA\u011eLIK R\u0130SKLER\u0130 OLU\u015eTURAB\u0130L\u0130R<\/p>\n

Di\u011fer taraftan DS\u00d6, sahte DEFITELIO kullan\u0131m\u0131 hastalar\u0131n etkisiz tedavisiyle sonu\u00e7lanabilece\u011fini belirterek, ilac\u0131n damari\u00e7i enjeksiyon ile kullan\u0131m\u0131n\u0131n \u00f6l\u00fcme varan ciddi sa\u011fl\u0131k riskleri olu\u015fturabilece\u011fine dikkat \u00e7ekti: \u201cDS\u00d6 \u015fu anda bu bildirilen sahte DEFITELIO\u2019nun kullan\u0131m\u0131n\u0131 takiben herhangi bir olay raporundan haberdar de\u011fildir, ancak bu uyar\u0131da at\u0131fta bulunulan sahte \u00fcr\u00fcnlerin g\u00fcvenli\u011fi, sterilitesi ve kalitesi bilinmemektedir.Siz veya tan\u0131d\u0131\u011f\u0131n\u0131z biri etkilenen \u00fcr\u00fcn\u00fc kulland\u0131ysa veya kullanm\u0131\u015f olabilece\u011fini d\u00fc\u015f\u00fcn\u00fcyorsan\u0131z veya kullan\u0131mdan sonra advers reaksiyon veya beklenmedik yan etki ya\u015fand\u0131ysa, derhal bir sa\u011fl\u0131k uzman\u0131ndan t\u0131bbi tavsiye alman\u0131z tavsiye edilir. Sa\u011fl\u0131k uzmanlar\u0131, olay\u0131 Ulusal D\u00fczenleyici Makamlara \/ Ulusal Farmakovijilans Merkezi\u2019ne bildirmelidir. Ulusal d\u00fczenleyici\/sa\u011fl\u0131k otoritelerinin bu sahte \u00fcr\u00fcnleri tespit etmeleri halinde DS\u00d6\u2019y\u00fc derhal bilgilendirmeleri tavsiye edilmektedir.\u201d T\u00fcm ila\u00e7lar\u0131n ve di\u011fer t\u0131bbi \u00fcr\u00fcnlerin yetkili ve lisansl\u0131 tedarik\u00e7ilerden sat\u0131n al\u0131nmas\u0131 gerekti\u011fini belirten DS\u00d6, bu \u00fcr\u00fcnlerin \u00fcretimi veya tedariki hakk\u0131nda herhangi bir bilgiye sahip olunmas\u0131 halinde rapidalert@who.int.lso adresinden DS\u00d6 ile ileti\u015fime ge\u00e7ilmesi gerekti\u011fini ifade etti.<\/p>\n","protected":false},"excerpt":{"rendered":"

Sak\u0131n Bu \u0130lac\u0131 Kullanmay\u0131n D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc Uyard\u0131 Sak\u0131n Kullanmay\u0131n.. devam\u0131 snraki syfada..<\/p>\n","protected":false},"author":1,"featured_media":1094,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1092","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/posts\/1092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/comments?post=1092"}],"version-history":[{"count":2,"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/posts\/1092\/revisions"}],"predecessor-version":[{"id":1096,"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/posts\/1092\/revisions\/1096"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/media\/1094"}],"wp:attachment":[{"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/media?parent=1092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/categories?post=1092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bilgitarif.com\/iyi\/wp-json\/wp\/v2\/tags?post=1092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}